As an extension of a previous study (de Vries et aL, 1995, J. Biol Chem., 270, 8712-8722) the acceptor specificity of recombinant FucT VI, expressed in insect cells as soluble enzyme, and purified from the growth medium by affinity chromatography, was analyzed toward a broad panel of oligosaccharide and glycoprotein substrates. It was found that FucT VI effectively utilizes any type-2-chain based structure (Gaipi-»4GlcNAc-R). Neutral as well as sialylated structures are fucosylated with high efficiency. To identify polar groups on acceptors that function in enzyme binding, deoxygenated substrate analogs were tested as acceptors. FucT VI had an absolute requirement for a hydroxyl at C-6 of galactose in addition to the accepting hydroxyl at C-3. Thus, FucT VI, although different from FucT m, IV, and V in acceptor properties, seems to bind the acceptor in a similar way.
Introduction
Several a3-fucosyltransferases (FucTs) differing in substrate specificities have been identified in human tissues or cells (Macher et al, 1991; de Vries and van den Eijnden, 1992) . Up to now, five cDNAs coding for fucosyltransferases have been cloned (Goelz et al., 1990; Kukowska-Latallo et al., 1990; Kumar et al, 1991; Lowe et al., 1991; Koszdin and Bowen, 1992; Weston et al., 1992a,b; Natsuka et al., 1994; Sasaki et al., 1994) . Their protein products show a high degree of sequence similarity and have been named FucT HI (KukowskaLatallo et al., 1990) , FucTTV (Goelz et al, 1990; Lowe et al., 1991; Kumar et al., 1991) , FucT V (Weston et al., 1992a) , FucT VI (Koszdin and Bowen, 1992; Weston et al, 1992b) , and FucT VH (Natsuka et al, 1994; Sasaki et al, 1994) . Some of these cloned enzymes have been related with enzyme activities detected in human tissues. FucT in has been identified as the Lewis enzyme, FucT IV as the myeloid enzyme, and FucT VI as the plasma enzyme. FucT VII has been detected in leukocytes. The expression pattern of FucT V has not yet been defined. Until now, no cDNA(s) has been assigned to the "lung-type" enzyme, identified by Holmes et al. (Holmes et al, 1986 . In most tissues multiple FucTs are expressed resulting in a mixture of enzymes, which makes it difficult to assign the observed activities to individual FucTs. Methods to detect their transcriptional expression such as Northern blot analysis or RT-PCR do not identify point mutations which can result in the production of inactive enzymes that would not contribute to the observed enzymatic activity (Mollicone et al., 1994a,b) . If, however, the acceptor specificity patterns of the recombinant enzymes are known and compared to the FucT activities in a certain tissue, it will be possible to determine whether a functionally active form of a particular FucT exists in a tissue.
In a previous paper we have begun a complete and systematic determination of the acceptor specificity of the recombinant fucosyltransferases FucT HI, FucT IV, and FucT V toward a broad panel of oligosaccharide, glycolipid, and glycoprotein substrates (de Vries et al., 1995) . It was found that FucT IH acts best on type-l-chain based structures (Gal|31->3GlcNAc-R), FucT IV acts well on neutral type-2-stmctures (Gaipi-»4GlcNAc-R), whereas FucT V has a rather broad specificity but displays low velocities. In the current study we have extended this analysis by investigating the substrate requirements of recombinant, soluble FucT VI. The aim of this study is 2-fold Firstly, knowledge of the acceptor preferences of the individual FucTs will allow the determination of the contribution of each enzyme to the fucosyltransferase activity in a given tissue. Secondly, it is more and more practice to take advantage of the fine specificities of enzymes instead of having to employ tedious chemical routes in the synthesis of carbohydrates for diagnostic or therapeutic applications. To make the proper choice of the appropriate enzyme required for a given product, substrate requirements of the enzymes have to be known in detail. It was concluded that FucT VI is the best enzyme to use for the synthesis of any a3-fucosylated type-2-chain based structure. Neutral as well as sialylated structures are fucosylated with high efficiency by this enzyme. We also found that the recombinant enzyme can very conveniently be produced via the baculovirus expression system. Large quantities of highly active, pure FucT VI can be obtained within a short period of time.
Results

Expression and purification of FucT VI protein
By PCR (using genomic DNA as template) a DNA fragment was prepared encoding the catalytic domain and part of the stem region of FucT VI, but lacking the transmembrane domain, and the cytoplasmic tail. The fragment was ligated into a transfer vector downstream of the melittin signal sequence for secretion and the polyhedrin promoter (Tessier et al, 1991) . Expression of this construct in insect cells, using the baculovirus system, resulted in the secretion of a soluble, enzymatically active form of FucT VI, starting at amino acid 34. No remaining FucT activity could be detected inside the insect cells. Expression of protein in the medium was optimal after 2 days of infection, in the presence of 10% FCS. Longer infection times did not result in an increase of FucT activity ( Figure  1 ). FucT VI was purified by affinity chromatography on GDPhexanolamine-Sepharose. The purified protein ran as a single band on SDS-PAGE, with an apparent molecular weight of 43,000 (Figure 2 ). N-Terminal sequencing identified this material as FucT VI and revealed an intact N-terminus without proteolytic degradation, starting at the predicted amino acid (data not shown).
In addition a recombinant form of FucT VI was prepared carrying an amino terminal His 6 -tag. However, purification using metal chelate chromatography resulted only in a 20-fold purification. Therefore, subsequent affinity chromatography on GDP-hexanolamine-Sepharose was required. The overall result of the two-step purification did not result in a greater enrichment for the His 6 -tagged protein than single step purification on GDP-hexanolamine-Sepharose for the FucT VI enzyme without any His-tag. Consequently, the latter enzyme was used in the subsequent acceptor specificity studies. Table I shows the results of the acceptor specificity of FucT VI towards oligosaccharide substrates. For comparison, the acceptor specificity of FucT DI, FucT IV, and FucT V from our previous study (de Vries et al., 1995) is added. FucT VI preferentially acted on type 2 chains (derivatives of Gaipi->4GlcNAc). The disaccharide LacNAc (1) was preferred over the tetrasaccharide lacto-N-neotetraose (3). Substitution of carbon-3 of terminal Gal with sialic acid or sulfate resulted in an improved acceptor property, whereas substitution with an al-»2-linked Fuc residue produced the best acceptor. FucT VI acted poorly on type 1 chain (Gaipi-»3GlcNAc) substrates, only the sialylated substrates (14,15) and LNT (12) were used with moderate efficiency. Lactose was a poor substrate, but substitution of the Gal residue with an a2-fucose enhanced fucose transfer. The glycoproteins tested all served as good acceptors for FucT VI (Table IT) . A slight preference for fetuin over a!-acid glycoprotein could be observed The activity ratio of sialylated versus neutral glycoprotein was 1.0 kDa 01 234567 Time (days post infection) for fetuin and 0.65 for AGP. Fetuin, in contrast to AGP, is known to contain more al-»3-linked sialic acid residues than a2-»6-linked residues.
Acceptor specificity of recombinant FucT VI
Kinetic studies
The K m of FucT VI for GDP-fucose, 9 ± 2 \iM, was identical to that of FucT IE, IV, and V (de Vries et al, 1995) . The apparent V and K m values of FucT VI for four type 2 acceptors (lacNAc, 2'-fucosyllacNAc, 3'-sialyllacNAc, and a sialylated "core-2" structure) are listed in Table HI . The apparent K m values ranged from 36 to 316 (iM, which are typical values for acceptor substrates with a hydrophobic aglycone. FucT VI showed the highest affinity for the sialylated trisaccharide 6. The maximum velocities for acceptors 2, 4, and 6 were in the same range. The sialylated "core-2" structure, however, showed a lower kinetic efficiency, suggesting that FucT VI might prefer to catalyze fucose addition to N-linked chains rather than O-linked.
Key polar groups
A series of deoxygenated analogs of type-1-chain-based and type-2-chain-based acceptors, in which one of the hydroxyl groups has been replaced by hydrogen, were employed to determine the groups required for substrate recognition and catalysis. The relative rates of transfer for the series are listed in Table IV . FucT VI, like FucT HI, IV, and V, required a hydroxyl group at C-6 of galactose and C-3 of GlcNAc. Compounds deoxygenated at these positions (24, 26) were neither acceptors, nor inhibitors at concentrations up to 5 mM. Therefore these groups are designated as key polar groups (Lemieux, 1989) . None of the type-1-chain-based substrates acted as an acceptor, not even after prolonged reaction times and use of undiluted enzyme. Substrates deoxygenated at C-2 or C-3 of Gal were not tested. Changes at these positions are tolerated, however, since fucosylation at C-2 or sialylation at C-3 generates a better acceptor substrate than nonsubstituted GalGlcNAc (Table HI) .
NEM inhibition assay
Fucosyltransferases have been classified by their sensitivity to inhibition by A'-ethylmaleimide (NEM), a cysteine modifying reagent (Mollicone et al., 1990) . FucT VI was significantly inhibited by NEM (more than 98%), consistent with the predictions made by Holmes et al. (1995) .
Discussion
For the production of glycosyltransferase proteins eukaryotic expression systems are preferred over bacterial systems. Expression of glycosyltransferases in E.coli often yields proteins which accumulate in inclusion bodies, and are mostly biologically inactive. One popular alternative to obtain properly folded enzyme is the baculovirus-insect cell expression system. It employs a recombinant baculovirus to infect insect cells in tissue culture. These cells are able to carry out posttranslational modifications that are similar to those produced in higher eukaryotes. Such modifications include the attachment of Oand N-linked carbohydrate chains, although the structure of these sugar chains is of the lacdiNAc-rather than the lacNActype (van Die et al, 1996) . The potential for N-glycosylation in insect cells is still under investigation, but N-linked glycans in general seem to be shorter than in mammals. Our group was the first to publish the successful expression of ot3-galactosyltransferase in high yield in baculovirus-infected insect cells (Joziasse et al., 1990) . Since then a variety of glycosyltransferases has been expressed in this system, in membrane-bound or in soluble form (among them FucT IH and FucT V; unpublished observations). The enzymatic properties of these enzymes were found to be very similar to those of the naturally occurring enzymes. In this study we positioned the FucT VI DNA in such a way that it was preceded by a sequence encoding the mellittin signal peptide. Using this construct the Table II The concentration of acceptor sites for each glycoprotein was calculated by galactose content. The final concentration was 2.2 mM. Relative rates for each acceptor are expressed as a percentage of the incorporation with compound 1 (Table I) . *O|-AGP contains slightly more a2-»6-linked than 02-O-linked sialic acid (Paulson et aL, 1982) . The branches of the N-linked chains in the preparation used were 96% sialylated. ''Fetuin contains some type 1 chain glycans on its N-linked branches (Townsend et aL, 1989) and contains ot2-> 3-linked and ct2-> 6-linked sialic acid on its N-linked glycans in an approximate ratio of 2:1 (Green et aL, 1988) . The branches of the N-linked chains in the preparation used were 90% sialylated. recombinant protein was secreted and could easily be collected from the growth medium, to be used in acceptor specificity studies. Human ot3-FucTs have been detected in a variety of tissues. Each tissue has its own very specific pattern of FucT expression. Extensive acceptor specificity analyses have been done on some of these enzymes (Macher et al., 1991; de Vries and van den Eijnden, 1992 , and references therein). This, and other biochemical criteria have been used to define several distinct enzyme species (Molliconeef al., 1990; Macher etal, 1991; de Vries and van den Eijnden, 1992) . The expression pattern of FucTs varies also from person to person. FucT HI, V, and VI, all located on chromosome 19, are polymorphous (Cameron et al., 1995) . The function of this varying expression of the various homologous FucT enzymes, remains unclear. People who are negative for FucT m, V, and VI appear to be perfectly healthy. FucT IV and FucT VII, however, seem to be necessary for proper functioning of the immune system (Maly et ah, 1996) .
Only partial analysis of the acceptor specificity of the cloned enzymes has been performed. Therefore, previously, we have determined the acceptor specificity of recombinant FucT HI, FucT IV, and FucT V toward a broad panel of oligosaccharide, glycolipid and glycoprotein substrates (de Vries et al., 1995) . In this study, we have complemented this analysis with the substrate specificity of a soluble, truncated form of FucT VI, using the same extensive collection of acceptors. Neutral type 2 structures function as good acceptors for the enzyme, while type 1 chains and lactose-based structures are poor acceptors. Fucosylation at C-2 or sialylation at C-3 of galactose enhances the capability to function as acceptor for FucT VI. Hence, the properties established in this study are similar to those of the enzymes purified from human serum (Samesto et al., 1992) , amniotic fluid (Hanisch et al., 1988) , hepatocytes (JezequelCuer et al., 1993) , and liver (Johnson et al., 1995) , suggesting that these enzymes are encoded by the gene for FucT VI.
Recently, it has been shown that the activity in serum and plasma is encoded by the FucT VI gene and that missense mutations are responsible for deficiency of this activity in 9% of the population of Java (Mollicone et al., 1994b) . A recent study from our laboratory showed that FucT VI, but not FucT TTT or FucT V, is responsible for the fucosylation of glycoproteins in the liver, and that this organ is a major source of the (soluble) FucT activity in plasma (Brinkman-van der Linden et al, 1996) . Transcripts of FucT VI are found in kidney, liver, colon, small intestine, bladder, uterus, and salivary glands (Cameron et al., 1995) . Soluble activities resembling FucT VI are also found in amniotic fluid and human milk. Milk contains both a3-and ot4-FucT activity. The acceptor specificity of the ct3-FucT activity in human milk shows exact resemblance to our results obtained with FucT VI (see Figure 3) , making it likely that the activity in milk is encoded by the FucT VI gene. The a4-FucT activity in milk is encoded by the Lewis or FucT TT1 gene (Mollicone et al., 1994a) and could be separated from the a3-FucT activity by chromatographic procedures (Johnson and Watkins, 1992; Gosselin and Palcic, 1996) . Figure 3 shows a comparison of the acceptor specificity pattern of FucT VI, human milk FucTs, and FucT HI. Clearly, our analysis shows that the pattern of human milk FucT (panel B) is a composite of the activity of FucT VI (panel A) plus the activity of FucT in (panel C). The kinetic parameters observed for FucT VI were in good agreement with those reported for the a3-FucT activity in human milk (Gosselin and Palcic, 1996) .
In a previous study (de Vries et al., 1995) , we mapped the hydroxyl groups on the acceptor structures which are recognized by the enzyme protein (i.e., key polar groups) for FucT TTT, IV, and V. It appeared that all these enzymes required the same hydroxyl groups: the hydroxyl at C-6 of galactose and the hydroxyl of C-3 or C-4 of GlcNAc. In this study we mapped the key polar groups necessary for binding to FucT VI. Again we found the groups to be similar the enzyme showed absolute requirements for a hydroxyl at the C-6 of galactose and the C-3 Table IV . Relative rates of transfer to deoxygenated of GlcNAc. The same was true for the a3-FucT activity purified from human milk (Gosselin and Palcic, 1996) . There was, however, a difference in toleration of modification at the C-6 of GlcNAc. FucT IV and FucT V acted very well on the substrate deoxygenated at C-6 of GlcNAc, while FucT VI and human milk a3-FucT (Gosselin and Palcic, 1996) acted only moderately on this substrate. FucT HI also showed a relatively lower activity towards the type 1 version of this substrate (de Vries et aL, 1995) . Recently, two groups narrowed down the area in the FucT polypeptide which is used to discriminate between the various acceptors (Legault et aL, 1995; Xu et aL, 1996) . There appears to be a short stretch of amino acids near the stem region in FucT El, FucT V, and Fuc TVI that causes these proteins to transfer to either a type 1 chain based or a type 2 chain based acceptor. Xu et al. (1996) identified a domain between amino acids 85 and 117 in FucT V which differentiates between type 1 or type 2 chains. In this region the residues in common between FucT V and FucT VI, but different from FucT m, may be involved in type 2 substrate recognition. However, from the domain swap study of Legault et al. (Legault et al., 1995) , an additional region of FucT VI was defined (between amino acids 102 and 126), which is unique to FucT VI, and which was concluded to determine type 2 substrate binding. Although these studies have identified regions (both in close proximity) for substrate discrimination, the exact amino acids that mediate binding to either a type 1 or a type 2 chain substrates are not known. Yet, we have established that the groups on the acceptor substrate recognized by the various ct3/4-FucTs are the same. Therefore, it seems likely that all a3/4-FucTs follow a similar folding pattern and have very similar catalytic pockets.
In conclusion, FucT VI can be utilized for preparative enzyme-assisted synthesis of any type-2-chain based structure. Neutral, as well as sialylated structures are fucosylated with high efficiency. The only limitation is the position of the key polar groups which are necessary for binding of the substrate to the enzyme.
Materials and methods
Materials
Oligonucleotide primers were obtained from Pharmacia. The baculovirus transfer vector pVTBac (Tessier et aL, 1991) was kindly supplied by Dr. T. Vemet and modified to incorporate a His 6 -Tag. Unlabeled GDP-fucose was a kind gift of Dr. Roger O'Neill (Perkin-Elmer, Foster City, CA) and the 8-methoxycarbonyloctyl glycoside acceptors (2, 4, 6, 8,11,13, and 14) were kindly provided by Dr. Ole Hindsgaul (University of Alberta, Edmonton, Alberta). Compound 7 was available from a previous study (Oehrlein et aL, 1993) . GDP-[
M C]Fuc (250 Ci/mol) was purchased from New England Nuclear (Boston) and diluted with the unlabeled nucleotide sugar to obtain the desired specific radioactivity, a,-Acid glycoprotein was prepared from human plasma Cohn fraction V supernatant as described (Hao and Wickerhauser, 1973) . Calf fetuin was obtained from Gibco. The corresponding asialo glycoproteins were prepared by mild acid hydrolysis (0.1 N trifluoroacetic acid, 1 h at 80°C). N-Acetyllactosamine (lacNAc), 1; lacto-W-biose I, 10; lactose, 16; 2'-fucosyllactose, 17 and 3'-sialyllactose, 18 were purchased from Sigma; lacto-W-neotetraose (LNnT), 3; 3'-sialyl-lacNAc, S; 6'-sialyl-lacNAc, 9; 3"-sialyl-LNT, 15 and lacto-jV-tetraose (LNT), 12 were purchased from Oxford GlycoSystems. All other chemicals were obtained from commercial sources and were of the highest purity available.
DNA constructs, and expression of FucT VI in insect celts
DNA encoding a truncated form (shortened at the 5' end) of FucT VI (Weston et aL, 1992' ) was produced by PCR using HL-60 cell genomic DNA (1 u.g) as a template. PCR reactions were performed in a final volume of 100 u.1 containing: buffer J (60 mM Tris.HCl pH 9.5, 15 raM (NH 4 ) I S0 4 , 2.0 mM MgCl 2 ) of the "PCR Optimizer kit" (Invitrogen), 10% DMSO, 1U Amplitaq DNA polyroerase (Perkin Elmer), and 10 pmol each of sequence-specific synthetic oligonucleotide primers FT61 (CCGAGCTCACGTGTGTCTCAAGAC) and FT62 (CGAATTCGGAAAATGAGGTTCCTGGC) containing Sad and EcoRl sites, respectively. Amplifications were carried out for 25 cycles using the following conditions: 1 min at 94°C, 1 min 57°C, and 1 min 72°C. A 1035 bp fragment was amplified, digested with Sad and EcoRl, and ligated into SacI/£coRI-digested pVTBac (Tessier ctaL, \99\) prior to amplification in the DH5a strain of E.coli. Nucleotide sequencing was performed by the dideoxy chain termination (Sanger et aL, 1977) method to check for PCR induced mutations. The T7 sequencing kit (Pharmacia), and several sequence-specific synthetic oligonucleotide primers were used. The FucT VI construct appeared to have a sequence identical to the published sequence (Weston a aL, 1992b) . The plasmid pVTBac-FT6 was isolated using the Qiagen "plasmid midi kit" and cotransfected with baculovirus DNA into Sf9 cells to allow recombination according to the Baculo Gold system (Pharmingen).
Enzyme preparation "High Five" insect cells (Trichoplusia ni) were obtained from Invitrogen and grown in "Hink's TNM-FH" medium supplemented with 10% fetal calf serum and 50 u.g/ml gentamycin. Cells were infected at a multiplicity of infection between 5 and 10. Growth medium was collected 2 days after infection, and stored frozen until use. FucT VI was purified from the medium by affinity chromatography on GDP-hexanolamine-Sepharose (synthesized according to Beyer et aL (1980) , ligand concentration 5.7 ujnol/ml gel). FucT VI was eluted from the column by washing with a buffer (25 raM sodium cacodylate, pH 7.2) containing 600 jiM GDP and 1 mM MnCl 2 , dialyzed against 25 mM sodium cacodylate buffer pH 7.2, containing 100 mM NaCl and 50% glycerol, and stored frozen until use. For enzyme carrying an amino terminal HiSs-tail, initial purification was performed using Zinc-chelale affinity chromatography (resin from Boehringer Mannheim). The column was washed with a buffer (25 mM sodium cacodylate, pH 7.3) containing 100 mM NaCl, and 25% glycerol Subsequent washes were performed with 1 and 10 mM imidazole, respectively, in the same buffer. Finally, enzyme was eluted with 100 mM imidazole in washing buffer.
Fucosyltransferase assays
The standard reaction mixture contained in 50 u.1: 5 nmol GDP-[ 14 C]Fuc (4-5 Ci/mol); 2.5 ujnol MOPS/NaOH pH 7.5; 1.0 ujnol MnCl 2 ; 5 ujnol NaCl; 0.2 jimol ATP; 50 nmol acceptor and 10 pj enzyme preparation. Reactions were run for 1 h at 37°C. Values were corrected for incorporation into endogenous acceptors. Three replicates were used per data point. One unit of activity was defined as the amount of enzyme catalyzing the transfer of 1 ujnol of fucose.min" 1 to an acceptor substrate.
Kinetic studies
The apparent K m for GDP-fucose was determined at 0.76 mM of compound 4 under the above assay conditions, while the GDP-Fuc concentration ranged from 0.5 to 32 \iM. Apparent kinetic parameters for the acceptor substrates were determined using a close to saturating concentration of GDP-fucose (50 (iM), with 5-6 acceptor concentrations generally ranging from 0.2 to 5 times K m for each acceptor. The results obtained were analyzed by fitting the initial rate data to the Michaelis-Menten equation using nonlinear regression analysis (Sigma Plot). Typical errors for V,,, are ±5%, and K^ ±10%.
